STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ELOX ELOXX PHARMACEUTICALS INCORPORATED StockScouter® Report

1

StockScouter® Score

ELOXX PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like ELOX

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The 50-day moving average for ELOX is significantly below its 200-day moving average. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

F
C
N/A
D

Previous Ratings

3
3